Macquarie Group
AUPH icon

Macquarie Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Macquarie Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,473
Closed -$10.8K – 1668
2024
Q3 		$10.8K Sell
1,473
-20,470
-93% -$127K ﹤0.01% 1623
2024
Q2 		$125K Hold
21,943
– – ﹤0.01% 1581
2024
Q1 		$7.48K Buy
21,943
+20,470
+1,390% +$139K ﹤0.01% 1601
2023
Q4 		$13.2K Hold
1,473
– – ﹤0.01% 1615
2023
Q3 		$11.4K Hold
1,473
– – ﹤0.01% 1607
2023
Q2 		$14.3K Buy
+1,473
New +$15.3K ﹤0.01% 1626
2022
Q4 		– Sell
-349
Closed -$11K – 1778
2022
Q3 		$11K Sell
349
-1,175
-77% -$10.2K ﹤0.01% 2338
2022
Q2 		$15K Hold
1,524
– – ﹤0.01% 2374
2022
Q1 		$19 Sell
1,524
-3,884
-72% -$60K ﹤0.01% 2401
2021
Q4 		$124K Buy
5,408
+4,233
+360% +$100K ﹤0.01% 1869
2021
Q3 		$26K Buy
+1,175
New +$18.6K ﹤0.01% 2390

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return